Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2022-12-15

Clinical Trial Update: The Influence of Fluid Removal Using Continuous Venovenous Hemofiltration (CVVH) on Intra-abdominal Pressure and Kidney Function [Phase 3]

View source ↗

Summary

Phase 3 trial investigating CVVH fluid removal effects on intra-abdominal pressure and kidney function was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Continuous venovenous hemofiltration

Snippet

Sponsor: University Hospital, Ghent | Conditions: Critically Ill, Intra-Abdominal Hypertension | Phase 3 | Status: WITHDRAWN